Abstract
lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: Clinical and biological effects. Ann Oncol 8:1041, 1997 31. Oberg K, Eriksson B: The role of interferons in the management of carcinoid tumors. Acta Oncol 30:519, 1991 32. Kaltsas GA, Papadogias D, Makras P, et al: Treatment of advanced neuroendocrine tumours with radiolabeled somatostatin analogues. Endocr Relat Cancer 12:683, 2005 33. Nilsson O, Kolby L, Bernhardt P, et al: GOT1 xenografted to nude mice: A unique model for in vivo studies on SSTR-mediated radiation therapy of carcinoid tumors. Ann N Y Acad Sci 1014:275, 2004 34. Kolby L, Bernhardt P, Johanson V, et al: Successful receptormediated radiation therapy of xenografted human midgut carcinoid tumour. Br J Cancer 93:1144, 2005 35. Kvols LK, Reubi JC, Horisberger U, et al: The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide. Yale J Biol Med 65:505, 1992 36. Chakravarthy A, Abrams RA: Radiation therapy in the management of patients with malignant carcinoid tumors. Cancer 75:1386, 1995 37. Schupak KD, Wallner KE: The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors. Int J Radiat Oncol Biol Phys 20:489, 1991
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
